Current Value
$34.501 Year Return
Current Value
$34.501 Year Return
SeekingAlpha
Attruby's approval makes BridgeBio Pharma a competitor to Vyndaqel, with significant potential for growth and milestone payments. Read my BBIO stock thesis.
Finnhub
By Sabela Ojea BridgeBio Pharma said it is fully financed to launch its cardiomyopathy treatment Attruby and read out its phase 3 clinical trials, which are fully enrolled. Shares rose 8.6%...
Finnhub
J.P. Morgan Presentation January 13, 2025 Key recent achievements: clinical impact ...
Finnhub
- Remarkable early Attruby demand: 430 scripts written by 248 unique HCPs since FDA approval with broad uptake across academic centers and community centers in all patient types - Fully enrolled...
Yahoo
PALO ALTO, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that co-founder and CEO, Neil Kumar, Ph.D., will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Monday, January 13 at 7:30 am PT. To access the live webcast of BridgeBio’s presentation, please visit the “Events & Presentations” page within the Investors
Yahoo
Evercore ISI raised the firm’s price target on BridgeBio (BBIO) to $50 from $45 and keeps an Outperform rating on the shares following Attruby’s approval and management discussions. The firm is updating its Attruby model to reflect 100% probability of success from 95%, pricing of $244,000 per year, and the firm’s increasingly constructive view on Attruby’s label, which could help future differentiation, the analyst tells investors in a research note. Evercore thinks its model is still conservati
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
GTE | <0.01% | $278.56M | +58.18% | 0.00% |
TSN | -0.04% | $19.56B | +4.57% | 3.52% |
REI | 0.06% | $289.37M | +14.06% | 0.00% |
SITC | -0.07% | $802.71M | +45.04% | 1.69% |
ROL | 0.08% | $23.39B | +10.48% | 1.26% |
CNR | 0.08% | $2.81B | -3.72% | 0.52% |
CI | 0.09% | $78.15B | -9.09% | 1.99% |
QNTM | 0.13% | $6.35M | -94.08% | 0.00% |
BTU | 0.13% | $2.30B | -25.72% | 1.59% |
KEP | 0.14% | $8.99B | +0.43% | 0.00% |
IP | -0.14% | $19.55B | +53.34% | 3.27% |
POAI | -0.16% | $8.93M | -50.74% | 0.00% |
ALL | 0.17% | $50.60B | +24.97% | 1.92% |
HRL | -0.17% | $16.41B | -3.83% | 3.81% |
RILY | -0.30% | $146.09M | -77.67% | 20.49% |
KGS | -0.33% | $4.12B | +117.42% | 3.31% |
PAA | 0.35% | $14.19B | +29.48% | 6.30% |
FF | 0.35% | $235.88M | +38.89% | 4.47% |
ASR | -0.35% | $7.42B | +1.62% | 0.00% |
VRN | -0.36% | $3.38B | -13.68% | 6.13% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BPMC | 47.10% | $6.60B | +30.46% | 0.00% |
CVCO | 40.42% | $3.82B | +47.03% | 0.00% |
HHH | 38.66% | $3.89B | +1.31% | 0.00% |
JOE | 37.87% | $2.83B | -10.84% | 1.06% |
AMWD | 37.84% | $1.22B | -12.05% | 0.00% |
TPH | 37.12% | $3.52B | +7.19% | 0.00% |
ALKS | 36.94% | $4.81B | +7.17% | 0.00% |
ARR | 36.92% | $1.03B | -2.94% | 15.56% |
ALRM | 36.64% | $3.03B | +1.47% | 0.00% |
MHO | 36.36% | $3.73B | +3.61% | 0.00% |
CLFD | 36.32% | $540.97M | +48.59% | 0.00% |
PFSI | 36.04% | $5.47B | +27.68% | 0.93% |
TMHC | 36.01% | $6.87B | +24.42% | 0.00% |
KBH | 35.89% | $5.01B | +11.67% | 1.39% |
CCS | 35.61% | $2.42B | -11.07% | 1.32% |
SFBS | 35.54% | $4.76B | +40.34% | 1.40% |
SYNA | 35.33% | $3.24B | -23.00% | 0.00% |
BCC | 35.31% | $4.93B | +0.65% | 0.63% |
SLVM | 35.23% | $3.25B | +68.17% | 2.06% |
ORA | 34.93% | $4.09B | +1.38% | 0.71% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LITB | -14.40% | $21.92M | -80.33% | 0.00% |
STG | -13.53% | $29.30M | -34.12% | 0.00% |
CBOE | -11.86% | $20.30B | +3.74% | 1.22% |
HUSA | -10.82% | $22.51M | +5.52% | 0.00% |
TCTM | -9.71% | $2.68M | -74.53% | 0.00% |
CME | -9.35% | $83.72B | +14.49% | 4.46% |
ALNY | -9.31% | $32.14B | +33.99% | 0.00% |
DOGZ | -9.06% | $562.95M | +1,227.93% | 0.00% |
FATBB | -8.54% | $80.77M | -20.10% | 11.55% |
BTCT | -8.50% | $23.92M | +5.78% | 0.00% |
COP | -8.50% | $136.61B | -1.05% | 2.77% |
NNE | -8.38% | $772.61M | +485.25% | 0.00% |
SYPR | -7.83% | $49.04M | +1.43% | 0.00% |
MNR | -7.74% | $1.82B | +2.15% | 18.25% |
TTE | -7.56% | $134.57B | -7.75% | 5.63% |
CTRA | -7.24% | $21.97B | +21.21% | 2.83% |
BSM | -7.09% | $3.27B | -3.90% | 10.33% |
SAVA | -6.78% | $129.42M | -89.62% | 0.00% |
WM | -6.53% | $84.69B | +14.99% | 1.42% |
IMO | -6.38% | $35.93B | +23.54% | 2.56% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 45.75% | $5.97B | 0.35% |
PBE | 43.27% | $249.05M | 0.58% |
IBB | 42.72% | $6.29B | 0.45% |
ARKG | 42.70% | $1.12B | 0.75% |
IWO | 41.78% | $12.82B | 0.24% |
XHE | 41.48% | $214.32M | 0.35% |
VTWO | 41.47% | $12.56B | 0.1% |
IWM | 41.30% | $72.20B | 0.19% |
XPH | 41.10% | $159.10M | 0.35% |
NUSC | 40.40% | $1.23B | 0.31% |
FXH | 40.12% | $1.06B | 0.62% |
VBK | 40.02% | $19.96B | 0.07% |
ITEQ | 39.87% | $95.20M | 0.75% |
FBT | 39.77% | $1.16B | 0.56% |
ESML | 39.68% | $1.92B | 0.17% |
ISCG | 39.62% | $650.49M | 0.06% |
VIOO | 39.33% | $3.13B | 0.1% |
PRFZ | 39.31% | $2.54B | 0.39% |
IWC | 39.30% | $962.03M | 0.6% |
KOMP | 39.08% | $2.09B | 0.2% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IXC | 0.17% | $1.96B | 0.41% |
IEO | 0.25% | $621.50M | 0.4% |
MINT | -0.50% | $12.10B | 0.35% |
CORN | 0.65% | $65.53M | 0.2% |
KCCA | -1.11% | $105.80M | 0.87% |
RSPG | 1.60% | $555.79M | 0.4% |
XLE | 1.88% | $35.04B | 0.09% |
FTXN | 2.13% | $168.31M | 0.6% |
IYE | 2.56% | $1.36B | 0.39% |
WEAT | -2.58% | $121.95M | 0.28% |
DRLL | 2.59% | $323.08M | 0.41% |
VDE | 2.62% | $8.04B | 0.1% |
GCC | -2.79% | $134.16M | 0.55% |
FENY | 2.83% | $1.59B | 0.084% |
CCOR | 3.05% | $82.79M | 1.18% |
DUSB | 3.13% | $939.32M | 0.15% |
FCG | 3.23% | $449.90M | 0.6% |
BSSX | 3.58% | $63.43M | 0.18% |
JUCY | 3.59% | $299.79M | 0.6% |
PXE | 4.17% | $108.61M | 0.63% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -17.42% | $195.31M | 0.85% |
UUP | -12.54% | $636.64M | 0.77% |
DBE | -11.12% | $50.40M | 0.77% |
USDU | -10.45% | $396.64M | 0.5% |
DBO | -10.14% | $220.74M | 0.77% |
CTA | -9.99% | $553.08M | 0.76% |
UNG | -9.79% | $852.04M | 1.06% |
USCI | -9.68% | $201.05M | 1.07% |
GSG | -9.21% | $1.06B | 0.75% |
COMT | -8.95% | $714.17M | 0.48% |
DBA | -8.74% | $817.28M | 0.93% |
DBC | -8.29% | $1.37B | 0.87% |
PDBC | -8.14% | $4.40B | 0.59% |
CANE | -7.84% | $11.58M | 0.29% |
TPMN | -7.72% | $41.98M | 0.65% |
FTGC | -6.96% | $2.32B | 1.02% |
BCD | -6.70% | $242.75M | 0.3% |
FLTR | -6.28% | $1.98B | 0.14% |
EQLS | -5.14% | $9.15M | 1% |
BCI | -4.43% | $1.37B | 0.26% |